Atorvastatin for Reduction of Myocardial Damage During Angiography and Its Mechanism Associated With IMR

Trial Profile

Atorvastatin for Reduction of Myocardial Damage During Angiography and Its Mechanism Associated With IMR

Recruiting
Phase of Trial: Phase II

Latest Information Update: 27 Feb 2017

At a glance

  • Drugs Atorvastatin (Primary)
  • Indications Angina pectoris; Myocardial infarction; Postmyocardial infarction; Unstable angina pectoris
  • Focus Therapeutic Use
  • Acronyms ARMYDA-IMR
  • Most Recent Events

    • 23 Jan 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top